Evidence map›Paper›PMID 34320912›Full record

ArticleVirulence2021

COVID-19 adaptive evolution during the pandemic - Implications of new SARS-CoV-2 variants on public health policies.

Cock van Oosterhout, Jessica F Stephenson, Bart Weimer, Hinh Ly, Neil Hall, Kevin M Tyler

Abstract readEditorial
In one paragraph

Article in Virulence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. COVID-19 Vaccines and the Virtues.Public health ethics · 2022
    Article
  5. Human SARS-CoV-2 has evolved to increase U content and reduce genome size.International journal of biological macromolecules · 2022
    Article
  6. Microbial adaptive evolution.Journal of industrial microbiology & biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cock van OosterhoutSchool of Environmental Sciences, Norwich Research Park, University of East Anglia, UKc.van-oosterhout@uea.ac.uk.ORCID 0000-0002-5653-738X
Jessica F StephensonDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0001-8939-5149
Bart WeimerSchool of Veterinary Medicine, Population Health and Reproduction, 100K Pathogen Genome Project, University of California Davis, Davis, CA, USA.ORCID 0000-0002-7471-1978
Hinh LyDepartment of Veterinary & Biomedical Sciences, University of Minnesota Twin Cities, St. Paul, MN, USA.ORCID 0000-0001-8271-2033
Neil HallEarlham Institute, Norwich Research Park, Norwich, UK.ORCID 0000-0003-2808-0009
Kevin M TylerCenter of Excellence for Bionanoscience Research, King Abdul Aziz University, Jeddah, Saudi Arabia.ORCID 0000-0002-0647-8158

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health PolicyCOVID-19Evolution, MolecularHumansPhysical DistancingRespiratory Protective DevicesSARS-CoV-2

Identifiers

PMID34320912
PMCPMC8330993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.